To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer

NCT01437254 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Neoplasms

Interventions

DRUG: CPERT
DRUG: GPERT

Sponsor

AHS Cancer Control Alberta

Collaborators

[object Object]
[object Object]